{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:37:43Z","timestamp":1793194663660,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","award":["2025A03J4180"],"award-info":[{"award-number":["2025A03J4180"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158420","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:06:49Z","timestamp":1781208409000},"page":"158420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Artesunate potentiates poly (ADP-ribose) polymerase inhibitor efficacy in ovarian cancer through RAD51-mediated homologous recombination repair impairment"],"prefix":"10.1016","volume":"161","author":[{"given":"Shimin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujiadai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6650-9252","authenticated-orcid":false,"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158420_bib0001","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1158\/1078-0432.CCR-16-2174","article-title":"Tumor BRCA1 reversion mutation arising during neoadjuvant platinum-based chemotherapy in triple-negative breast cancer is associated with therapy resistance","volume":"23","author":"Afghahi","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0002","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1200\/JCO.2010.28.5791","article-title":"Personalizing therapy for ovarian cancer: bRCAness and beyond","volume":"28","author":"Bast","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.07.010","article-title":"RAD51 protects human cells from transcription-replication conflicts","volume":"82","author":"Bhowmick","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2026.158420_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-genet-021920-092410","article-title":"RAD51 gene family structure and function","volume":"54","author":"Bonilla","year":"2020","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.phymed.2026.158420_bib0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158420_bib0006","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: a review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMa"},{"key":"10.1016\/j.phymed.2026.158420_bib0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-cancerbio-030617-050502","article-title":"Homology-directed repair and the role of BRCA1, BRCA2, and related proteins in genome integrity and cancer","volume":"2","author":"Chen","year":"2018","journal-title":"Annu Rev. Cancer Biol."},{"key":"10.1016\/j.phymed.2026.158420_bib0008","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0009","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdy099","article-title":"RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer","volume":"29","author":"Cruz","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0010","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.30764","article-title":"RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies","volume":"141","author":"Gachechiladze","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158420_bib0011","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrclinonc.2016.191","article-title":"Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer","volume":"14","author":"George","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0012","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1158\/1078-0432.CCR-10-1027","article-title":"A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer","volume":"16","author":"Graeser","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.09.003","article-title":"Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition","volume":"71","author":"Haynes","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2026.158420_bib0014","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1158\/2159-8290.CD-17-0419","article-title":"Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma","volume":"7","author":"Kondrashova","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2026.158420_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012583","article-title":"Base excision repair","volume":"5","author":"Krokan","year":"2013","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"key":"10.1016\/j.phymed.2026.158420_bib0016","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","article-title":"Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial","volume":"15","author":"Ledermann","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0017","first-page":"280","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158420_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12957-024-03544-w","article-title":"Inhibition of HOXC11 by artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2\/PI3K\/AKT pathway","volume":"22","author":"Li","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0019","first-page":"1724","article-title":"The mechanism of artesunate combined with cytarabine and\/or daunorubicin on the apoptosis of MV4-11 MLL-rearranged acute myeloid leukemia cell line","volume":"30","author":"Li","year":"2022","journal-title":"Zhongguo Shi. Yan. Xue Ye Xue Za Zhi."},{"key":"10.1016\/j.phymed.2026.158420_bib0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","article-title":"Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2026.158420_bib0021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jpp\/rgaf006","article-title":"Natural product pulsatilla saponin D sensitizes BRCA-proficient ovarian cancers to PARP inhibitors through inhibiting homologous recombination repair","volume":"77","author":"Lin","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158420_bib0022","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1158\/1078-0432.CCR-15-1348","article-title":"RAD51 mediates resistance of cancer stem cells to PARP inhibition in triple-negative breast cancer","volume":"23","author":"Liu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0023","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1021\/acsomega.5c12071","article-title":"Nanowire-mediated eradication of polymicrobial biofilms","volume":"11","author":"Ma","year":"2026","journal-title":"ACS. Omega"},{"key":"10.1016\/j.phymed.2026.158420_bib0024","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","article-title":"Artesunate sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy","volume":"20","author":"Ma","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2026.158420_bib0025","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","article-title":"A decade of clinical development of PARP inhibitors in perspective","volume":"30","author":"Mateo","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0026","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"Mccabe","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0027","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.annonc.2020.06.004","article-title":"The forefront of ovarian cancer therapy: update on PARP inhibitors","volume":"31","author":"Mirza","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158420_bib0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1097-2765(01)00174-5","article-title":"BRCA2 is required for homology-directed repair of chromosomal breaks","volume":"7","author":"Moynahan","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2026.158420_bib0029","first-page":"665","article-title":"PARP inhibitors: clinical development, emerging differences, and the current therapeutic issues","volume":"2","author":"Murthy","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.phymed.2026.158420_bib0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/1541-7786.MCR-17-0455","article-title":"PARP1 trapping and DNA replication stress enhance radiosensitization with combined WEE1 and PARP inhibitors","volume":"16","author":"Parsels","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0031","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.dnarep.2013.02.001","article-title":"Co-ordination of base excision repair and genome stability","volume":"12","author":"Parsons","year":"2013","journal-title":"DNA Repair"},{"key":"10.1016\/j.phymed.2026.158420_bib0032","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158420_bib0033","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature18325","article-title":"Replication fork stability confers chemoresistance in BRCA-deficient cells","volume":"535","author":"Ray Chaudhuri","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158420_bib0034","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","journal-title":"Redox. Biol."},{"key":"10.1016\/j.phymed.2026.158420_bib0035","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1158\/0008-5472.CAN-09-1178","article-title":"Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma","volume":"69","author":"Sakai","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158420_bib0036","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158420_bib0037","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.7150\/thno.104858","article-title":"Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2026.158420_bib0038","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4265\/jmc.28.1_35","article-title":"Synergy analysis with extended isobolography and its conceptual basis for the evaluation of antimicrobial effects of combined physical and chemical treatments","volume":"28","author":"Tsuchido","year":"2023","journal-title":"J. Microorg. Control"},{"key":"10.1016\/j.phymed.2026.158420_bib0039","doi-asserted-by":"crossref","first-page":"33425","DOI":"10.1074\/jbc.M114.564567","article-title":"Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin","volume":"289","author":"Yang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2026.158420_bib0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2026.158420_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154259","article-title":"Artesunate: a review of its therapeutic insights in respiratory diseases","volume":"104","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158420_bib0042","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature24060","article-title":"BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing","volume":"550","author":"Zhao","year":"2017","journal-title":"Nature"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326006513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326006513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:07:09Z","timestamp":1793192829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326006513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":42,"alternative-id":["S0944711326006513"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158420","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate potentiates poly (ADP-ribose) polymerase inhibitor efficacy in ovarian cancer through RAD51-mediated homologous recombination repair impairment","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158420"}}